Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab

Completed · Phase 1/Phase 2

Conditions studied: Colon Cancer With Metastases to the Liver

In brief

This is a multicentre, open labeled, controlled phase study designed to assess effectiveness of chemoembolization with LC Beads, both with and without systemic chemotherapy, in the treatment of unresectable liver metastases in patients with colorectal cancer.

Key facts

Study ID

NCT00932438

Run by

University of Louisville

People needed

70

Starts

2009-06-01

Expected to finish

2012-12-01

Last updated by the study team

2021-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Clearview Cancer Center — Huntsville, Alabama, United States
• Radiology Associates of Sacramento/Sutter Cancer Center — Sacramento, California, United States
• Emory University — Atlanta, Georgia, United States
• Northside Hospital/GA Cancer Specialists — Atlanta, Georgia, United States
• University of Louisville — Louisville, Kentucky, United States
• Hematology and Oncology Assoc. at Bridgeport — Tupelo, Mississippi, United States
• Washington University/Alvin J. Siteman Cancer Center — St Louis, Missouri, United States
• Providence Portland Medical Center/Providence Cancer Center — Portland, Oregon, United States
• Froedtert Memorial Lutheran Hospital — Milwaukee, Wisconsin, United States
• Hospital Italiano de Buenos Aires — Buenos Aires, Argentina

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.